PerkinElmer and Invitrogen in ion channel deal
PerkinElmer and Invitrogen enter into a strategic agreement to streamline drug development in which the collaboration will combine PerkinElmer's technology for ion channel drug discovery and Invitrogen's voltage sensor probe reagents.